Home/Filings/4/0001209191-21-026826
4//SEC Filing

O'Donnell Niall 4

Accession 0001209191-21-026826

CIK 0001637715other

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 4:16 PM ET

Size

14.0 KB

Accession

0001209191-21-026826

Insider Transaction Report

Form 4
Period: 2021-04-13
Transactions
  • Conversion

    Common Stock

    2021-04-13+1,034,6001,034,600 total(indirect: By RiverVest Venture Fund IV, L.P.)
  • Conversion

    Series A Preferred Stock

    2021-04-134,629,6300 total(indirect: By RiverVest Venture Fund IV, L.P.)
    Common Stock (1,034,600 underlying)
  • Conversion

    Series B Preferred Stock

    2021-04-133,710,1160 total(indirect: By RiverVest Venture Fund IV, L.P.)
    Common Stock (829,113 underlying)
  • Conversion

    Common Stock

    2021-04-13+829,1131,863,713 total(indirect: By RiverVest Venture Fund IV, L.P.)
  • Purchase

    Common Stock

    2021-04-13$15.00/sh+200,000$3,000,0002,063,713 total(indirect: By RiverVest Venture Fund IV, L.P.)
Footnotes (3)
  • [F1]All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 4.4748 shares of Preferred Stock. The Preferred Stock had no expiration date.
  • [F2]The shares held by RiverVest Venture Fund IV, L.P. ("RiverVest Fund IV") are indirectly held by RiverVest Venture Partners IV, L.P., its general partner ("RiverVest Partners IV"). RiverVest Venture Partners IV, LLC is the general partner of RiverVest Partners IV. The individual managers of RiverVest Ventures Partners IV, LLC are Jay Schmelter, John P. McKearn, Ph.D. and the Reporting Person. RiverVest Partners IV, RiverVest Venture Partners IV, LLC and each of the individual managers (including the Reporting Person) share voting and dispositive power with regard to the Company's securities directly held by RiverVest Fund IV.
  • [F3]The shares were purchased in the Issuer's initial public offering.

Issuer

Reneo Pharmaceuticals, Inc.

CIK 0001637715

Entity typeother

Related Parties

1
  • filerCIK 0001780235

Filing Metadata

Form type
4
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 4:16 PM ET
Size
14.0 KB